Paulson & Co. - LOXO ONCOLOGY INC ownership

Quarter-by-quarter ownership
Paulson & Co. ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q3 2017$2,100,000
-96.2%
22,800
-96.7%
0.04%
-94.9%
Q2 2017$55,082,000
+61.1%
686,893
-15.5%
0.74%
+64.1%
Q1 2017$34,190,000
+28.5%
812,500
-1.9%
0.45%
+35.5%
Q4 2016$26,612,000
+37.9%
828,641
+12.4%
0.34%
+60.3%
Q3 2016$19,293,000
+232.5%
736,941
+194.4%
0.21%
+254.2%
Q2 2016$5,803,000
-5.8%
250,341
+11.1%
0.06%
+28.3%
Q1 2016$6,161,000
+163.5%
225,341
+174.2%
0.05%
+228.6%
Q4 2015$2,338,00082,1790.01%
Other shareholders
LOXO ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital LLC 4,188,920$385,883,00063.39%
DAFNA Capital Management LLC 262,121$24,147,00014.99%
Casdin Capital, LLC 360,000$33,163,0009.36%
Opaleye Management Inc. 130,000$11,975,0004.24%
SECTORAL ASSET MANAGEMENT INC 245,226$22,590,0002.91%
BVF INC/IL 238,386$21,960,0002.79%
Crawford Lake Capital Management, LLC 81,725$7,529,0002.70%
AWM Investment Company, Inc. 125,000$11,515,0002.01%
Orbimed Advisors 1,728,000$159,183,0001.52%
Eventide Asset Management 285,000$26,254,0001.49%
View complete list of LOXO ONCOLOGY INC shareholders